Clinical Trial Update: A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Participants When Injected Under the Skin. [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating NNC0487-0111 in Chinese participants completed, describing how the drug behaves after subcutaneous injection in individuals with over…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• NNC0487-0111

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Overweight, Obesity | Phase 1 | Status: COMPLETED